NCT04154618

Brief Summary

This study evaluates the feasibility and usability of continuous wireless vital sign monitoring of well newborns during their birth hospitalization.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2020

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 11, 2019

Completed
26 days until next milestone

First Posted

Study publicly available on registry

November 6, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

February 18, 2020

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 18, 2023

Status Verified

April 1, 2023

Enrollment Period

5.2 years

First QC Date

October 11, 2019

Last Update Submit

April 14, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of feasibility by questionnaires to nurses and mothers using the using the Technology Acceptance Model (TAM).

    TAM questionnaires will be distributed to the nurse taking care of each subject at the time of discharge of the infant. The questionnaire will include informed consent by the nurse for participation in the research. A similar questionnaire will also be distributed to the mother just prior to discharge.

    Up to 3 days

Secondary Outcomes (2)

  • Accuracy assessed by comparison to conventional vital sign measurements within a 2-minute window

    Up to 3 days

  • Clinical Utility as measured by false alerts

    Up to 3 days

Interventions

Infants will receive wireless vital sign monitoring throughout their birth hospitalization.

Eligibility Criteria

Age0 Hours - 12 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Healthy newborn infants \< 12 hours of age admitted to the Well Baby Nursery

You may qualify if:

  • Healthy infants \<12 hours of age
  • Expected to be admitted to the Well Baby Nursery
  • or more weeks gestation at birth
  • Mother at least 18 years of age

You may not qualify if:

  • Infants requiring any non-routine medical care or observation
  • Neonatal Intensive Care Unit (NICU) or Special Care Nursery admission
  • Multiple birth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cohen Children's Medical Center of New York

New Hyde Park, New York, 11040, United States

RECRUITING

Phelps Hospital

Sleepy Hollow, New York, 10591, United States

NOT YET RECRUITING

Central Study Contacts

Barry Weinberger, MD

CONTACT

Debra C Potak, RN

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 11, 2019

First Posted

November 6, 2019

Study Start

February 18, 2020

Primary Completion

April 30, 2025

Study Completion

December 31, 2025

Last Updated

April 18, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will share

All individual participant data (IPD).

Shared Documents
CSR
Time Frame
Data will become available after enrollment is complete and all data have been collected
Access Criteria
Requests to the principal investigator (PI) to obtain data outlining the purpose of the study, the data elements to be accessed, preferred method of transmission, and preferred file type. For requests of identifiable information or information utilizing a limited data set a copy of valid institutional review board (IRB) approval and informed consent, as applicable. The PI will evaluate the request and ensure that appropriate regulatory approvals have been obtained. Once approved the investigator will be informed and relevant data transferred for analysis.

Locations